YDES

YD Bio Limited - Ordinary Shares (YDES)

About YD Bio Limited - Ordinary Shares (YDES)

YD Bio Ltd. is a biotechnology company building an integrated healthcare platform across regulated diagnostics, clinical services, and commercial healthcare markets. It operates DNA methylation–based oncology testing programs under an LDT-first strategy and provides compliant life science distribution and clinical trial supply chain services to pharmaceutical and biotechnology partners. The company’s offerings include cancer detection products, regenerative ophthalmology solutions, and exosome-based technologies. YD Bio was founded on February 6, 2024 and is headquartered in Taipei, Taiwan.

Details

Daily high

$4.00

Daily low

$3.38

Price at open

$3.50

52 Week High

$25.00

52 Week Low

$1.70

Market cap

238.7M

Dividend yield

Volume

87,779

Avg. volume

37,628

P/E ratio

-3.41

YD Bio Limited - Ordinary Shares News